Stage IIIB Breast Cancer Completed Phase 1 / 2 Trials for Tipifarnib (DB04960)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00070252Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast CancerTreatment
NCT00470301Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast CancerTreatment